Oral therapy of lindan resistant Norwegian scabies;Orale Therapie einer lindanresistenten Scabies crustosa mit Ivermectin

H+G Zeitschrift fur Hautkrankheiten

Volumn 72, Issue 2, 1997, Pages 121-126

  Qadripur, S A ^a   Schauder, S ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

crusted scabies; epidemic; ivermectin; lindan resistance; Norwegian scabies; outbreaks of scabies

Indexed keywords

IVERMECTIN; LINDANE;

AGED; ARTICLE; CASE REPORT; DIABETES MELLITUS; DRUG EFFICACY; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; SCABIES; TOPICAL DRUG ADMINISTRATION;

EID: 0030892822     PISSN: 03010481     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Arliane, L.G., S.A. Este, D.L. Vyszenski-Moher (1988): Prevalence of Sarcoptes scabies in the Environment of Scabies Patients. J. Amer. Acad. Dermatol. 19, 809-811.
2. Aubin F., P. Humbert (1995): Ivermectin for crusted (Norwegian) Scabies. New Engl. J. Med. 332, 612.
3. Calnan, C.D. (1950): Crusted Scabies. Brit. J. Dermatol. 114:71 - 78.
4. Campbell, W.C (1989): Ivermectin and Abamectin. Springer-Verlag Berlin, Heidelberg, New York.
5. Clark, J., D.L. Friesen, W.A. Williams (1992): Management of an outbreak of Norwegian Scabies. Amer. J. Infect. Contr. 20, 217 - 220.
6. Craslaw, R.W., R.M. Dobson, A.J.K. Hood, R.N. Taylor (1975): Mites in the environment of cases of Norwegian Scabies. Br. J. Dermatol. 92: 333 - 337.
7. De Santolo, G.P., P. Maragnani, G.A. Tacchini, M Fantasto, A. De Santolo (1996): Gale norvegienne: Analyse d'un cas. Dermatol. 32, 10 - 12.
8. Dick, G., W. Burgdorf, W. Gentry (1979): Norwegian Scabies in Blooms's Syndrome. Arch. Dermatol. 115,212 - 213.
9. Dilon, S.M. (1989): An HIV-infected patient with an extraordinary rash. Hospital Practice 24,199 - 200.
10. Donabedian H., U. Khazan ((1992): Norwegian Scabies in a Patient with AIDS. Clin. Infect. Dis. 14,162 - 164.
11. Dunne, C.L., C J Malone, J.A. Whitworth (1991): A field study of the effect of ivermectin on ectoparasites of man. Transact. Roy. Soc. Trop. Med. Hyg. 85, 550 - 551.
12. Este, A., J, Este (1992): Therapy of Scabies: Nursing Homes, Hospitals and the Homeless. Sem. Dermatol. 12, 26 - 33
13. Glaziou, P., J.L. Cartel, P. Alzien, C. Briot, J.P. Monlia- Pelat, P.M. Martin (1993). Comparison of ivermectin and benzyl benzoate for treatment of scabies. Trop. Med. Parasitol. 44, 331 - 332.
14. Goa, K.L., D. Mc Tavish, S.P. Clissold (1991): Ivermectin - A Review of its Antifilarial Activity. Pharmacokinetic Properties and Clinical Efficacy in Onchocerciasis. Drugs 42, 640 - 658.
15. Greene, B.W., K.P. Brown, H.R. Taylor (1989): Use of Ivermectin in humans. In: Ivermectin and Abamectin. Ed. N,L. Campbell, Springer-Verlag, Berlin Heidelberg, New York.
16. Hall, J.C., J.H. Brewer, B.S. Appl (1989): Norwegian Scabies in a patient with acquired immune deficiency syndrome. Cutis 43, 325 - 329.
17. Hopper, A.H., S. Salisbury, A.N. Jagadeva, B. Scott, G.C.T. Bennett (1990): Epidemic Norwegian Scabies in a Geriatric Unit. Age Aging 19, 125 - 127.
18. Hubler, W.R., W. Clabaugh (1978): Epidemic Norwegian Scabies. Arch. Dermatol. 112, 179 - 181.
19. Inserra, D.W., M.D. Bickley (1990): Crusted Scabies in acquired immuno-deficiency syndrome. Int. J. Derrnatol. 29, 287 - 289.
20. Jessurun, J., J. Romo-Garcia, O. Lopez-Denis (1990): Crusted scabies in a patient with the acquired immunodefiniency syndrome. Virchows Arch. Pathol. 416, 461 - 463.
21. Judge M.R., R. Kobza-Black (1995). Crusted scabies in pregnancy. Br. J. Dermatol. 132, 116 - 119.
22. Kar, S.K., J. Mania, K.S. Patnaik (1994): The use of ivermectin for scabies. Natl. Med. J. Ind. 7, 15- 16.
23. Kim, K.W., Y. Jin Oh, B.K. Cho, W. Houh, J.A. Kim, Y.S. Lee (1990): Norwegian Scabies: Dissemination of Mites by Medical Instruments. Ann. Dermatol. 2, 50 - 54.
24. Klein L.J., G. Cole (1987): Crusted Scabies in a diabetic alcoholic. Int. J. Dermatol. 26, 467 - 468.
25. Lerche, N.W., R.W. Cumer, D.D. Juranek, W. Baer, N.J. Dubay (1983): Atypical crusted (norwegian) scabies. Report of a nosocomial transmission in a community hospital and an approach for control. Cutis, 637 - 669.
26. Logan, J.O.P., P.W. Grant, P.B. Keczkes (1967): Norwegian Scabies and Lymphatic Leukemia. Br. J. Dermatol. 79, 303 - 305
27. Martin-Prevel, Y., J.Y. Cosnefroy, P. Tshipamha, P. Ngari, J.A. Chodakewitz, M. Pinder (1993): Tolerance and efficacy of single high-dose ivermectin for the treatment of loiasis. Amer. J. Trop. Mad. Hyg. 43, 186 - 192
28. Meinking, I.I., D. Taplin, J.L. Hermida, A. Padro, F.A. Kerdel (1995): The treatment of scabies with ivermectirt. New Engl. J. Med. 333, 26 - 30 (1995)
29. Mellanby, K. (1943): Scabies. Oxford University Press, London, 43
30. Mellanby, K. (1972): Scabies. Classy.
31. Millard, LG. (1977): Norwegian scabies developing during treatment with fluorinated steroids therapy. Acta Dermatovenerol. 57, 86 - 88.
32. O'Donnel, B.F., S. O'Longhlin, F.C. Powell (1990): Management of crusted scabies, Int. J. Dermatol. 29, 258 - 266.
33. Orkin, M. (1993): Scabies in AIDS. Sem. Dermatol. 12, 9 - 14.
34. Ottesen, E.A., W.C. Campbell (1994): Ivermectin in human medicine. J. Antimicr. Chemother. 34, 195 - 203.
35. Paterson, W.D., B.R. Allen, G.W. Bevendge (1973): Norwegian Scabies dunng Immunosuppressive Therapy. Br. Med. J. 4, 211 - 212.
36. Purvis, R.S., Tyring, S.K. (1991): An outbreak of lindane-resistant scabies treated successfully with permethnn 5% cream. J. Am. Acad. Dermatol. 25, 1015-1017.
37. Rau, B.C., I.E. Baird (1986): Crusted scabies in human immunodeficiency syndrome. J. Amer. Acad. Dermatol. 15, 1058 - 1059.
38. Schulz-Key, H (1994): Ivermectin (Mectizian) Kurzbewertung. Arzneim. Ther. Folge 4, 896 - 897.
39. Suzumiya, J., A. Sumiyoshi, Y. Kuroki (1985): Crusted (Norwegian) Scabies with adult T-Cell-Leukemia. Arch. Dermatol. 121, 903 - 904.
40. Wishart, J. (1972): Norwegian Scabies: A Christchurch Epidemic. Aust. J. Dermatol. 13, 127- 131.
41. Witkowski, J.A., Parish, L.C. (1992): Lindane-Resistant Scabies. J. Am. Acad. Dermatol. 27, 648
42. Youshock, E., S.D. Glazer (1981): Norwegian scabies in a renal transplant patient. JAMA 246, 2608 - 2609